Skip to main content

Table 1 Baseline characteristics of 401 patients initially presenting with acute dyspnea or peripheral edema

From: Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I

Variables

All patients

No AHF

AHF

p value*

(n = 401)

(n = 279)

(n = 122)

Demographics

    

 Age, mean (range)

67 (18–96)

65 (18–96)

73 (36–96)

0.0001

 Male, n (%)

205 (51)

131 (47)

74 (61)

0.7

Cardiovascular risk factors, n (%)

    

 Arterial hypertension

268 (67)

170 (61)

98 (80)

0.0001

 Hypercholesterinemia

122 (30)

207 (74)

72 (59)

0.003

 Cardiac family history

132 (33)

97 (35)

35 (27)

0.3

 Smoking

206 (51)

148 (53)

58 (48)

0.3

 Diabetes mellitus

120 (30)

67 (24)

53 (43)

0.0001

Main diagnoses, n (%)

    

 Chronic CHF

143 (36)

63 (23)

80 (66)

0.0001

 Atrial fibrillation

90 (22)

40 (14)

50 (41)

0.0001

 Coronary artery disease

130 (32)

73 (26)

57 (47)

0.0001

 Prior myocardial Infarction

89 (22)

47 (17)

42 (34)

0.0002

 Valvular heart disease

118 (29)

48 (17)

70 (57)

0.0001

 Acute exacerbated COPD

31 (8)

27 (10)

4 (3)

0.03

 Acute exacerbated asthma

7 (2)

7 (3)

0 (0)

0.1

 Pneumonia

20 (5)

19 (7)

1 (1)

0.01

 Pulmonary embolism

12 (3)

12 (4)

0 (0)

0.02

 Chronic kidney disease

71 (17)

30 (11)

41 (34)

0.0001

 Cancer

19 (5)

19 (7)

0 (0)

0.001

 Stroke

10 (2)

8 (3)

2 (2)

0.7

 LV EF (%), median (interquartile range)

41 (30–52)

50 (40–58)

39 (27–50)

0.04

Symptoms and signs, n (%)

    

 Peripheral edema

46 (11)

42 (15)

4 (3)

0.02

 Dyspnea

235 (59)

183 (66)

52 (42)

0.0001

 Both peripheral edema and dyspnea

120 (30)

54 (19)

66 (54)

0.0001

  1. *p values for the comparison between AHF and no AHF group